ATE407140T1 - Verfahren zur herstellung von cyclosporin- derivaten - Google Patents

Verfahren zur herstellung von cyclosporin- derivaten

Info

Publication number
ATE407140T1
ATE407140T1 AT99957167T AT99957167T ATE407140T1 AT E407140 T1 ATE407140 T1 AT E407140T1 AT 99957167 T AT99957167 T AT 99957167T AT 99957167 T AT99957167 T AT 99957167T AT E407140 T1 ATE407140 T1 AT E407140T1
Authority
AT
Austria
Prior art keywords
cyclosporin
preparing
optionally
cyclosporine derivatives
derivatives
Prior art date
Application number
AT99957167T
Other languages
English (en)
Inventor
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE407140T1 publication Critical patent/ATE407140T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT99957167T 1998-06-22 1999-06-21 Verfahren zur herstellung von cyclosporin- derivaten ATE407140T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807846A FR2780061B1 (fr) 1998-06-22 1998-06-22 Nouveau procede de preparation de derives de cyclosporine

Publications (1)

Publication Number Publication Date
ATE407140T1 true ATE407140T1 (de) 2008-09-15

Family

ID=9527672

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957167T ATE407140T1 (de) 1998-06-22 1999-06-21 Verfahren zur herstellung von cyclosporin- derivaten

Country Status (8)

Country Link
US (3) US7226905B2 (de)
EP (1) EP1098903B1 (de)
JP (1) JP4224213B2 (de)
AT (1) ATE407140T1 (de)
AU (1) AU4270099A (de)
DE (1) DE69939470D1 (de)
FR (1) FR2780061B1 (de)
WO (1) WO1999067280A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143604A0 (en) 1998-12-30 2002-04-21 Dexcel Ltd Dispersable concentrate for the delivery of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
KR100465012B1 (ko) * 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
IL150600A (en) * 2001-07-19 2005-09-25 Akzo Nobel Nv Process for the preparation of compounds containing one or more amide bonds using an excess of an activated carboxylic component and scavenging the residual activated carboxylic component
TWI247012B (en) * 2001-07-19 2006-01-11 Akzo Nobel Nv Process for rapid solution synthesis of peptides
KR20040039622A (ko) * 2002-11-04 2004-05-12 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US6987090B2 (en) * 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
KR20070009674A (ko) * 2004-04-08 2007-01-18 노파르티스 아게 대뇌 허혈 및 뇌와 척수 상해에서의 ｎｉｍ８１１
RU2399628C2 (ru) * 2004-10-01 2010-09-20 Скайнексис, Инк. Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с
US7196161B2 (en) 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
EP1933859A2 (de) 2005-09-30 2008-06-25 Scynexis, Inc. Verfahren und pharmazeutische zusammensetzungen zur behandlung und prävention von hepatitis-c-infektionen
WO2007041631A1 (en) 2005-09-30 2007-04-12 Scynexis, Inc. ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION
CN101511357B (zh) 2006-05-19 2011-11-02 西尼克斯公司 环孢菌素类化合物及其组合物在制备治疗和预防眼部疾病的药物中的应用
EP2027761A1 (de) * 2006-06-02 2009-02-25 Claude Annie Perrichon Verwaltung von aktieven elektronen
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
WO2010002428A2 (en) * 2008-06-06 2010-01-07 Scynexis, Inc. Novel macrocyclic peptides
CN102307892A (zh) 2008-12-31 2012-01-04 西尼克斯公司 环孢菌素a的衍生物
JP2012528163A (ja) * 2009-05-27 2012-11-12 アラーガン、インコーポレイテッド 炎症性疾患および状態を処置するためのシクロスポリン誘導体
CN102834409A (zh) 2009-12-30 2012-12-19 西尼克斯公司 环孢菌素类似物
MX353720B (es) 2010-12-15 2018-01-25 Contravir Pharmaceuticals Inc Moleculas analogas de ciclosporina modificadas en el aminoacido 1 y 3.
JP2015532277A (ja) 2012-09-29 2015-11-09 ノバルティス アーゲー 環状ペプチドおよび医薬としてのその使用
US10227877B2 (en) 2016-08-18 2019-03-12 General Electric Company Cooling circuit for a multi-wall blade
WO2020037530A1 (en) * 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (de) 1985-03-11 1992-07-29 Sandoz Ag Cyclosporine
JPH0267244A (ja) * 1988-09-01 1990-03-07 Wako Pure Chem Ind Ltd β−ヒドロキシ脂肪酸の製法
US4937355A (en) 1989-01-17 1990-06-26 E. R. Squibb & Sons, Inc. Process for preparing (trans)-4-substituted-dl-proline derivatives
EP0484281B2 (de) * 1990-11-02 2000-11-22 Novartis AG Zyklosporine
JPH0793927B2 (ja) * 1990-11-02 1995-10-11 富士通株式会社 超音波カラードプラ診断装置
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2772768B1 (fr) * 1997-12-19 2000-01-14 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine

Also Published As

Publication number Publication date
EP1098903A1 (de) 2001-05-16
US7226905B2 (en) 2007-06-05
JP2002518519A (ja) 2002-06-25
US20010025025A1 (en) 2001-09-27
US20100173838A1 (en) 2010-07-08
JP4224213B2 (ja) 2009-02-12
DE69939470D1 (de) 2008-10-16
US7678766B2 (en) 2010-03-16
US20070213260A1 (en) 2007-09-13
EP1098903B1 (de) 2008-09-03
AU4270099A (en) 2000-01-10
FR2780061A1 (fr) 1999-12-24
WO1999067280A1 (fr) 1999-12-29
FR2780061B1 (fr) 2001-09-07

Similar Documents

Publication Publication Date Title
ATE407140T1 (de) Verfahren zur herstellung von cyclosporin- derivaten
WO2003072026A3 (en) Method of reducing and treating uvb-induced immunosuppression
ATE469908T1 (de) Verfahren zur herstellung von pimecrolimus
DE69916435D1 (de) Verfahren zur verbesserung der ductilität von nitinol
WO2003102153A3 (en) Cell migration inhibiting compositions and methods and compositions for treating cancer
PL328858A1 (en) Immunogenous peptides
ATE271555T1 (de) Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DK1135163T3 (da) Topiske sammensætninger indeholdende ascomyciner
DE59204480D1 (de) Verfahren zur Herstellung von tert.-Butoxycarbonyl-Gruppen tragenden organischen Verbindungen.
ES2191061T3 (es) Antibioticos sinteticos.
MXPA03001536A (es) (aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DE60131085D1 (de) Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
DE69728473D1 (de) Alkalimetall-formomonetin und verfahren zur mycorrhizalen stimulierung
DE69616913T2 (de) Verfahren zur Herstellung von 3,7-Dimethyl-5,7-octadien-1-ol oder Rosenoxid
DE69707825D1 (de) Verfahren zur Herstellung von alicyclischen Hydrazin-derivaten.
DE69617685D1 (de) Zusammensetzung und verfahren zur stabilisierung von radiomarkierten organischen verbindungen
DE69932342D1 (de) Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums
DE59813058D1 (de) Verfahren zur Herstellung von Enzymen bzw. Enzymkomplexen
DE50100344D1 (de) Verfahren zur Herstellung von substituierten 10-Chlor-phenoxaphosphinen oder 10-Brom-phenoxaphosphinen
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
ZA200110213B (en) The use of the protein UK 114 for inhibiting organ transplant rejection.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties